Skip to main content

January 24, 2019

Monthly Member Spotlight:

With the aging of the population and lack of definitive treatments for osteoarthritis (OA), the public health impact of this disease continues to grow. The importance of conducting research to reduce the burden of OA cannot be overstated. OARSI (Osteoarthritis Research Society International) is the leading medical society for advancing the understanding, early detection, treatment and prevention of OA through its exclusive dedication to research. With more than 30 years of experience serving the OA community, OARSI provides the necessary framework, expert resources, and support for its international constituents to address the challenges of OA so that the knowledge gained can ultimately be used to help improve patient care and patient outcomes.

We appreciate our strong relationship with OARSI and the high-quality research they promote that
informs our public health messaging and action. Our upcoming Lunch and Learn Webinars in February and March feature Drs. Gillian Hawker and Nigel Arden regarding OARSI’s efforts to obtain recognition for OA as a serious disease. You can register for this webinar series below. We recognize and appreciate the great work that OARSI does every day to promote and support research for OA. 


Upcoming OAAA Lunch and Learn Webinars
The burden of OA Series

Part 1: February 20th at 12pm ET with Dr. Gilllian Hawker – Topic: OA is a Serious Disease 

Part 2: March 20th at 12pm ET with Dr. Nigel Arden – Topic: TBD

An Interview with Jeffrey Katz and the Osteoarthritis Research Society International

Jeffrey N. Katz, MD, MSc, OARSI President

1. What is your organization’s interest in the Osteoarthritis
Action Alliance?

The Osteoarthritis Research Society International (OARSI) is the premier research organization in the world focused on osteoarthritis. Our members conduct research to prevent and improve the quality of life of persons with osteoarthritis. We use a range of disciplinary lenses, including prevention, diagnosis, treatment (exercise, nutrition, rehabilitation, medication, surgery, others), policy, fundamental disease mechanisms and translation from bench to bedside, among others. The OARSI mission is tied inextricably to the lives of persons affected by osteoarthritis, the clinicians who help care for these patients and the policies that inform care of osteoarthritis.  The OAAA has been remarkably effective in developing a community of individuals and organizations (including OARSI) dedicated to preventing OA and improving the quality of life of those with OA. In this sense, OARSI and the OAAA are fellow travelers, working on behalf of persons with or at risk of osteoarthritis.

2. What do you think is the most important issue today related to osteoarthritis?

We have so many challenges, it is difficult to isolate one. That said, many in the field argue that our greatest challenge is that we do not yet have a therapy that can arrest or reverse the course of osteoarthritis.  I am excited by the work being done in academic and industry laboratories around the world attempting to identify and validate a disease-modifying therapy. We’re getting closer.

3. How does your work connect to issues in osteoarthritis?

OARSI members are engaged in groundbreaking research, translation of research findings to clinical practice and evaluation of practice to identify opportunities for improvement. We publish findings from these efforts in various venues including our own journal, Osteoarthritis and Cartilage (and our online journal, which will be publishing its first articles later in 2019). Our members speak to audiences around the world disseminating research findings. We work with the Food and Drug Administration in the US and analogous bodies elsewhere in the world to guide policy on use of medications in OA.

4. What is a headline you’d like to see about osteoarthritis in five years?

“Recent data show that rates of total joint replacement, work disability and activity limitation in persons with osteoarthritis are diminishing”

5. What is one interesting fact you’d like people to know about your organization?

We are diverse! Our members reside in numerous countries throughout North, Central and South America, Europe, Asia, Africa and the Middle East, Australia and New Zealand. We have had several satellite meetings in Asian countries in the last few years. About half of our members see patients in some capacity. We come together for an annual congress in the spring (Toronto this year) to trade ideas, form and sustain collaborations and to kindle and nurture friendships.



Osteoarthritis Research Society International
Resources & Events

2019 OARSI World Congress on Osteoarthritis
May 2-5, 2019 – Toronto, Canada
The annual OARSI Congress is the pre-eminent multidisciplinary global forum for all those interested in cutting edge OA research from academia and industry around the world. Attend this meeting to join a global network of individuals from a broad range of disciplines, all working toward a better understanding of OA with the goals of preventing, managing and curing the disease. Registration is open! Early bird discount registration through April 2, 2019.

OARSI Educational Resources
The OARSI Resource Library contains the speaker slides from the World Congresses on Osteoarthritis as well as guidelines, outcome and physical measures and white papers.

Hey OA! Podcast
One of OARSI young investigators, Kerry Costello, will be interviewing a new guest for each monthly episode and will cover topics ranging from groundbreaking new research to clinical care and policy, knowledge translation, career paths and more. Take a look at their archive list of podcasts and download the app on the app store.

And make sure to connect with The Association of Rheumatology Health Professionals through The American College of Rheumatology Social Media platforms! 

Twitter           Facebook        Linkedin    YouTube

Comments are closed.